Skip to main content
. 2014 Sep 18;111(10):1985–1992. doi: 10.1038/bjc.2014.489

Figure 5.

Figure 5

Receiver operating characteristic (ROC) curves for the ability of the four individual miRNAs (AD) and the 4-miRNA panel (E) to differentiate the CAC patients from the control group in the training phase. Comparison of ROC curves for the ability of the 4-miRNA panel and carcinoembryonic antigen (CEA) (F) to differentiate the CAC patients from the control group in the validation phase.